-
Recalled Neoral® 100 mg soft gelatin capsules -
Recalled Sandimmune® 100 mg soft gelatin capsules
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act (PPPA), posing a risk of poisoning if the contents are swallowed by young children.
Novartis toll-free at 866-629-6182 from 8 a.m. to 8 p.m. ET daily, email at Novartis5060@stericycle.com or online at www.pharma.us.novartis.com and in the top navigation of the page go to the News tab and click on Statements, or visit https://www.pharma.us.novartis.com/news/statements/corrective-action-certain-100-mg-sandimmune-and-neoral-blister-packages-us for more information.
Recall Details
This recall involves blister packages of prescription medications Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules and Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules from Novartis. Packages of Sandimmune 100 mg contain three blister cards with ten soft gelatin capsules per card and packages of Neoral 100 mg contain five blister cards with six soft gelatin capsules per card. The recalled blister packages have “Novartis,” the name of the medication, dosage, NDC, lot number and expiration date on the outer package and on the blister cards. Only 100 mg doses of these medications with the following NDC and lot numbers and expiration dates are included in this recall:
|
Recalled Prescription Drugs |
NDC Numbers |
Lot Numbers |
Expiration Date |
|
Sandimmune® (cyclosporine capsules, USP) 100 mg soft gelatin capsules |
0078-0241-15 0078-0241-61 |
APCA136 APCA339 APCA793 APCC238 |
09/2020 02/2021 01/2022 07/2022 |
|
Neoral® (cyclosporine capsules, USP) MODIFIED 100 mg soft gelatin capsules |
0078-0248-15 0078-0248-61 |
APCA437 APCA979 |
07/2020 03/2021 |
Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.
None reported.
Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.
Related Recalls
The portable fuel bottles do not meet the child-resistant requirements for closures under the Children's Gasoline Burn Prevention Act (CGBPA). The closure for the products is not child-resistant, posing a risk of burn and poisoning to children.
The speaker’s lithium-ion battery can overheat and catch fire, posing burn and fire hazards to consumers.
The outer packaging meant to prevent access to the contents can split open near the zipper track, posing a risk of serious injury to children and other vulnerable populations if the contents of the laundry detergent packets are ingested, as well as posing a risk of skin or eye injuries. Ingestion of a large quantity of any surfactant-containing household cleaning products can cause death among individuals with underlying health issues.
The portable fuel containers violate the child-resistant requirements for closures under the Children's Gasoline Burn Prevention Act (CGBPA). The closure for the products is not child resistant, posing a risk of burns and poisoning to children.
Compressed helium from the tank can escape and cause the plastic cap to be released into the air unexpectedly, posing an injury hazard due to projectiles striking users and bystanders.
The candy’s rolling ball can detach from the product’s container into a child’s mouth, posing a choking hazard for consumers.
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.
- Visit CPSC.gov.
- Sign up to receive our email alerts.
- Follow us on Facebook, Instagram @USCPSC and Twitter @USCPSC.
- Report a dangerous product or product-related injury on www.SaferProducts.gov.
- Call CPSC’s Hotline at 800-638-2772 (TTY 800-638-8270).
- Contact a media specialist.
